Literature DB >> 9173928

Characterization of an expanded glutamine repeat androgen receptor in a neuronal cell culture system.

B P Brooks1, H L Paulson, D E Merry, E F Salazar-Grueso, A O Brinkmann, E M Wilson, K H Fischbeck.   

Abstract

Spinal and bulbar muscular atrophy (SBMA) is an inherited form of lower motor neuron degeneration caused by expansion of a CAG repeat in the androgen receptor (AR) gene. To study the mechanism by which this mutation causes neuronal pathology, we stably transfected a motor neuron hybrid cell line with human AR cDNAs containing either 24 or 65 repeats (AR24 and AR65, respectively). Both forms of receptor were able to bind ligand and activate transcription of a reporter construct equally well. Likewise, the subcellular localizations of AR24 and AR65 were similar, in both the presence and the absence of ligand. AR24- and AR65-expressing clones were phenotypically indistinguishable. They survived equally well after differentiation and were equally susceptible to damage by oxidative stress. Our studies thus demonstrate that, in a neuronal system, the expanded repeat AR functions like the normal repeat AR in several important ways. Because levels of AR65 expression were consistently lower than levels of AR24 expression, we propose that the loss of function of AR seen in SBMA may be due to decreased levels of receptor expression rather than to a difference in intrinsic properties. The postulated gain of function responsible for neuronal degeneration remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9173928     DOI: 10.1006/nbdi.1997.0126

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  27 in total

Review 1.  Polyglutamine pathogenesis.

Authors:  C A Ross; J D Wood; G Schilling; M F Peters; F C Nucifora; J K Cooper; A H Sharp; R L Margolis; D R Borchelt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Increased T-type Ca2+ channel activity as a determinant of cellular toxicity in neuronal cell lines expressing polyglutamine-expanded human androgen receptors.

Authors:  A Sculptoreanu; H Abramovici; A A Abdullah; A Bibikova; V Panet-Raymond; D Frankel; H M Schipper; L Pinsky; M A Trifiro
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

Review 3.  Kennedy disease.

Authors:  K H Fischbeck
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

4.  Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients.

Authors:  Christopher Grunseich; Kristen Zukosky; Ilona R Kats; Laboni Ghosh; George G Harmison; Laura C Bott; Carlo Rinaldi; Ke-lian Chen; Guibin Chen; Manfred Boehm; Kenneth H Fischbeck
Journal:  Neurobiol Dis       Date:  2014-06-09       Impact factor: 5.996

Review 5.  Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Andrew P Lieberman
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-12       Impact factor: 4.388

Review 6.  In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.

Authors:  Maria Pennuto; Manuela Basso
Journal:  J Mol Neurosci       Date:  2015-11-27       Impact factor: 3.444

7.  Characterization of intracellular aggregates using fluorescently-tagged polyglutamine-expanded androgen receptor.

Authors:  V Panet-Raymond; B Gottlieb; L K Beitel; H Schipper; M Timiansky; L Pinsky; M A Trifiro
Journal:  Neurotox Res       Date:  2001-07       Impact factor: 3.911

8.  Generation of neuronal intranuclear inclusions by polyglutamine-GFP: analysis of inclusion clearance and toxicity as a function of polyglutamine length.

Authors:  K L Moulder; O Onodera; J R Burke; W J Strittmatter; E M Johnson
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

Review 9.  Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives.

Authors:  Masahisa Katsuno; Hiroaki Adachi; Fumiaki Tanaka; Gen Sobue
Journal:  J Mol Med (Berl)       Date:  2004-02-27       Impact factor: 4.599

10.  Numerous microRNPs in neuronal cells containing novel microRNAs.

Authors:  Josée Dostie; Zissimos Mourelatos; Michael Yang; Anup Sharma; Gideon Dreyfuss
Journal:  RNA       Date:  2003-02       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.